Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / HGEN - Relief Therapeutics Discovers A Promising COVID-19 Killer


HGEN - Relief Therapeutics Discovers A Promising COVID-19 Killer

Relief Therapeutics Holdings AG (RLFTF) is a Swiss Company that trades on the U.S. OTC Exchange in addition to its Swiss Stock Exchange Listing (RLF). Only a week ago, Relief Therapeutics was trading under .10 per share. It was the rediscovery of the properties of their drug RLF-100, a proprietary synthetic form of Vasoactive Intestinal Polypeptide (VIP) also known as aviptadil, which has led to the justifiable interest in the company.

In a previous article, I described my rationale for following potential Covid-19 therapeutics over potential vaccines, and the progression of the

Read more ...

Stock Information

Company Name: Humanigen Inc.
Stock Symbol: HGEN
Market: OTC
Website: humanigen.com

Menu

HGEN HGEN Quote HGEN Short HGEN News HGEN Articles HGEN Message Board
Get HGEN Alerts

News, Short Squeeze, Breakout and More Instantly...